Literature DB >> 28734760

PD-1 inhibition in metastatic dMMR/MSI-H colorectal cancer.

Francesco Sclafani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28734760     DOI： 10.1016/S1470-2045(17)30512-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  16 in total

Review 1.  Recent advances in Lynch syndrome.

Authors:  Leah H Biller; Sapna Syngal; Matthew B Yurgelun
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

2.  Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel.

Authors:  Zhen Yu; Xundou Li; Jinhong Duan; Xian-Da Yang
Journal:  Int J Nanomedicine       Date:  2020-09-11

3.  Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability.

Authors:  Ganjun Yu; Wenying Wang; Xiaobo He; Jia Xu; Rongrong Xu; Tao Wan; Yanfeng Wu
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

4.  Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy.

Authors:  Fengkun Lu; Lei Hou; Sizhen Wang; Yingjie Yu; Yunchang Zhang; Linhong Sun; Chen Wang; Zhiqiang Ma; Feng Yang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 5.  Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature.

Authors:  Burcin Baran; Nazli Mert Ozupek; Nihal Yerli Tetik; Emine Acar; Omer Bekcioglu; Yasemin Baskin
Journal:  Gastroenterology Res       Date:  2018-02-08

6.  RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.

Authors:  Zhen-Yu Liu; Ming Zheng; Yi-Ming Li; Xin-Yu Fan; Jian-Chao Wang; Zhu-Chun Li; Hai-Jiao Yang; Jing-Min Yu; Jian Cui; Jian-Li Jiang; Juan Tang; Zhi-Nan Chen
Journal:  Theranostics       Date:  2019-06-02       Impact factor: 11.556

Review 7.  Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle.

Authors:  Yuan Zhuang; Chang Liu; Jiaqing Liu; Guang Li
Journal:  Onco Targets Ther       Date:  2020-01-07       Impact factor: 4.147

8.  Should immunohistochemical expression of mismatch repair (MMR) proteins and microsatellite instability (MSI) analysis be routinely performed for poorly differentiated colorectal neuroendocrine carcinomas?

Authors:  Tu Vinh Luong; Zaibun Nisa; Jennifer Watkins; Aimee R Hayes
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-07-29

Review 9.  Lynch Syndrome: Its Impact on Urothelial Carcinoma.

Authors:  Andrea Katharina Lindner; Gert Schachtner; Gennadi Tulchiner; Martin Thurnher; Gerold Untergasser; Peter Obrist; Iris Pipp; Fabian Steinkohl; Wolfgang Horninger; Zoran Culig; Renate Pichler
Journal:  Int J Mol Sci       Date:  2021-01-07       Impact factor: 5.923

10.  Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.

Authors:  Ting Xu; Yinjie Zhang; Jing Zhang; Changsong Qi; Dan Liu; Zhenghang Wang; Yanyan Li; Congcong Ji; Jian Li; Xuan Lin; Ting Hou; Hao Liu; Lu Zhang; Han Han-Zhang; Lin Shen; Xicheng Wang
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.